Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Targeted cellular immunotherapy for T cell malignancies

Nature Medicine volume 23, pages 1402–1403 (2017)Cite this article

Subjects

In a recent study, Maciocia et al. develop a novel T cell receptor beta (TCRB) constant C1-chain-directed cellular immunotherapy for the treatment of T cell malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Principles of anti-TCRB-C1 CAR T cell therapy.

References

  1. Pishko, A. & Nasta, S.D. Transl. Cancer Res. 6, 93–103 (2017).

    Article  CAS  Google Scholar 

  2. Ramos, C.A. et al. J. Clin. Invest. 126, 2588–2596 (2016).

    Article  Google Scholar 

  3. Toyonaga, B., Yoshikai, Y., Vadasz, V., Chin, B. & Mak, T.W. Proc. Natl. Acad. Sci. USA 82, 8624–8628 (1985).

    Article  CAS  Google Scholar 

  4. Schwartz, R.H. Annu. Rev. Immunol. 3, 237–261 (1985).

    Article  CAS  Google Scholar 

  5. Warner, K. et al. Curr. Hematol. Malig. Rep. 8, 163–172 (2013).

    Article  Google Scholar 

  6. Nikolich-Zugich, J., Slifka, M.K. & Messaoudi, I. Nat. Rev. Immunol. 4, 123–132 (2004).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Cancer Genetics, Columbia University, New York, New York, USA

    Teresa Palomero & Adolfo Ferrando

  2. Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA

    Teresa Palomero & Adolfo Ferrando

  3. Department of Pediatrics, Columbia University Medical Center, New York, New York, USA

    Adolfo Ferrando

Authors
  1. Teresa Palomero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adolfo Ferrando
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adolfo Ferrando.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Palomero, T., Ferrando, A. Targeted cellular immunotherapy for T cell malignancies. Nat Med 23, 1402–1403 (2017). https://doi.org/10.1038/nm.4458

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4458

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing